Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ

$5.31

-$0.04 (-0.75%)

At close: Oct 30, 2026, 4:00 PM ET

$5.20

-$0.11 (-2.07%)

Pre-market: Nov 2, 2026, 6:37 AM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025
PE Ratio	-2.82	-3.53	-10.20	n/a
PEG Ratio	-0.43	-0.86	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	1.51	1.04	-0.92	n/a
P/FCF Ratio	-2.73	-2.95	-7.81	n/a
P/OCF Ratio	-2.76	-3	-8.02	n/a
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.54	0.46	-0.29	-0.30
Quick Ratio	9.89	11.75	6.34	8.80
Current Ratio	9.89	11.75	6.34	8.80
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a
Return on Equity	-18.95%	-15.06%	9.06%	8.84%
Return on Assets	-11.34%	-9.75%	-13.39%	-11.07%
Return on Invested Capital	-12.73%	-10.71%	-15.13%	-12.30%
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a